Division of Pediatric Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Eur J Pediatr Surg. 2024 Feb;34(1):97-101. doi: 10.1055/a-2156-5099. Epub 2023 Aug 18.
Peroral endoscopic myotomy (POEM) is a minimally invasive endoscopic procedure for achalasia; its indication has expanded from adults to children. We aimed to evaluate the postoperative efficacy and antireflex status of POEM in young children with achalasia aged 12 years or younger.
AND METHODS: Pediatric patients with achalasia aged 18 years or younger who underwent POEM in our hospital between 2016 and 2021 were included and divided into two age groups: group A (≤ 12 years) and group B (13-18 years). The success rate (Eckardt score ≤ 3), endoscopic reflux findings, and antiacid use at 1 year postoperatively were compared between the groups.
Ten patients (four boys and six girls; Chicago classification type I: five, type II: four, and unclassified: one) were included. Mean age and preoperative Eckardt scores in groups A ( = 4) and B ( = 6) were 9.2 ± 3.0 versus 15.6 ± 0.6 years ( = 0.001) and 5.5 ± 3.9 versus 7.2 ± 3.7 ( = 0.509), respectively, and mean operative time and myotomy length were 51.3 ± 16.6 versus 52.5 ± 13.2 minutes ( = 0.898) and 10.8 ± 4.6 versus 9.8 ± 3.2 cm ( = 0.720), respectively. The 1-year success rate was 100% in both groups. Mild esophagitis (Los Angeles classification B) was endoscopically found in one patient in each group (16.7 vs. 25.0%, = 0.714), and antiacid use was required in three patients (group A, two; group B, one; 50.0 vs. 16.7%, = 0.500).
The success rate of POEM within 1 year in young children with achalasia aged 12 years or younger was equal to that in adolescent patients. However, young children tended to require antiacids 1 year postoperatively; therefore, long-term follow-up is necessary.
经口内镜下肌切开术(POEM)是治疗贲门失弛缓症的一种微创内镜方法,其适应证已从成人扩展到儿童。我们旨在评估 POEM 在 18 岁或以下患有贲门失弛缓症的幼儿中的术后疗效和抗反流状态。
2016 年至 2021 年期间,在我院接受 POEM 治疗的 18 岁或以下患有贲门失弛缓症的儿科患者被纳入研究,并分为两组:A 组(≤12 岁)和 B 组(13-18 岁)。比较两组术后 1 年的成功率(Eckardt 评分≤3)、内镜反流情况和抗酸药物使用情况。
10 例患儿(男 4 例,女 6 例;芝加哥分类 I 型:5 例,II 型:4 例,未分类:1 例)被纳入研究。A 组(n=4)和 B 组(n=6)的平均年龄和术前 Eckardt 评分分别为 9.2±3.0 岁和 15.6±0.6 岁(P=0.001),5.5±3.9 分和 7.2±3.7 分(P=0.509),平均手术时间和肌切开长度分别为 51.3±16.6 分钟和 10.8±4.6 厘米和 52.5±13.2 分钟和 9.8±3.2 厘米(P=0.898 和 P=0.720)。两组患儿术后 1 年的成功率均为 100%。两组各有 1 例患儿(16.7%和 25.0%,P=0.714)内镜下发现轻度食管炎(洛杉矶分类 B),有 3 例患儿(A 组 2 例,B 组 1 例)需要使用抗酸药物(50.0%和 16.7%,P=0.500)。
12 岁或以下患有贲门失弛缓症的幼儿 POEM 术后 1 年的成功率与青少年患者相当。然而,幼儿术后 1 年往往需要使用抗酸药物,因此需要长期随访。